DENTSPLY SIRONA Inc. $XRAY Stock: Cooke & Bieler LP Trims Position

Cooke & Bieler LP decreased its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 26.5% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 5,089,385 shares of the medical instruments supplier’s stock after selling 1,838,530 shares during the period. Cooke & Bieler LP’s holdings in DENTSPLY SIRONA were worth $45,092,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. BlackRock Inc. purchased a new stake in DENTSPLY SIRONA in the second quarter valued at approximately $283,405,000. Southpoint Capital Advisors LP purchased a new position in DENTSPLY SIRONA during the first quarter worth about $116,000,000. Edmond DE Rothschild Holding S.A. acquired a new stake in shares of DENTSPLY SIRONA in the 2nd quarter valued at approximately $47,780,000. Paradigm Capital Management Inc. NY acquired a new position in shares of DENTSPLY SIRONA during the 2nd quarter worth $39,775,000. Finally, Bank of America Corp DE purchased a new position in DENTSPLY SIRONA in the second quarter valued at about $31,001,000. Institutional investors and hedge funds own 95.70% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently commented on XRAY shares. Leerink Partners lowered their price objective on shares of DENTSPLY SIRONA from $14.00 to $10.00 and set a “market perform” rating on the stock in a research note on Wednesday, October 14th. Barrington Research set a $15.00 target price on shares of DENTSPLY SIRONA in a research report on Monday, August 10th. Weiss Ratings reiterated a “sell (e+)” rating on shares of DENTSPLY SIRONA in a report on Monday, August 3rd. Piper Sandler cut their price objective on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a report on Friday, October 9th. Finally, BMO Capital Markets reduced their price target on shares of DENTSPLY SIRONA from $13.00 to $10.00 and set a “market perform” rating on the stock in a research report on Thursday, September 17th. Three investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $12.92.

DENTSPLY SIRONA Stock Up 2.4%

XRAY stock opened at $9.08 on Thursday. The company has a debt-to-equity ratio of 1.48, a current ratio of 1.63 and a quick ratio of 1.07. The firm has a fifty day moving average price of $9.95 and a two-hundred day moving average price of $10.97. The firm has a market cap of $1.81 billion, a price-to-earnings ratio of -3.30, a PEG ratio of 1.13 and a beta of 0.87. DENTSPLY SIRONA Inc. has a 1-year low of $8.32 and a 1-year high of $14.76.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Thursday, August 6th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.35 by $0.17. The company had revenue of $898.00 million for the quarter, compared to analysts’ expectations of $889.93 million. DENTSPLY SIRONA had a positive return on equity of 20.84% and a negative net margin of 14.99%. The firm’s quarterly revenue was down 4.1% compared to the same quarter last year. During the same period last year, the business posted $0.52 earnings per share. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. Research analysts predict that DENTSPLY SIRONA Inc. will post 1.39 EPS for the current year.

About DENTSPLY SIRONA

DENTSPLY SIRONA is a global manufacturer of professional dental products and technologies. The company serves dentists, dental specialists, dental laboratories and other oral health professionals with solutions used in preventive, restorative, prosthetic, endodontic and implant dentistry.

Its portfolio includes dental equipment, imaging and treatment systems, CAD/CAM technology, consumable dental materials, orthodontic products, endodontic instruments and solutions, dental implants, prosthetic components and laboratory products.